应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
06132 华健未来-B
已收盘 11-12 16:08:04
33.440
+0.300
+0.91%
最高
34.980
最低
32.120
成交量
8.18万
今开
33.140
昨收
33.140
日振幅
8.63%
总市值
24.60亿
流通市值
24.60亿
总股本
7,356万
成交额
269.19万
换手率
0.11%
流通股本
7,356万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
华健未来-B回购4,000股,耗资约12.95万港元
公告速递 · 11-11 17:36
华健未来-B回购4,000股,耗资约12.95万港元
华健未来-B11月10日回购9000股,耗资约28.69万港元
公告速递 · 11-10 17:51
华健未来-B11月10日回购9000股,耗资约28.69万港元
华健未来-B(06132.HK)11月10日斥资约28.69万港元回购9000股
智通财经 · 11-10 17:47
华健未来-B(06132.HK)11月10日斥资约28.69万港元回购9000股
华健未来-B:11月9日回购9,000股,耗资约28.85万港元
公告速递 · 11-09
华健未来-B:11月9日回购9,000股,耗资约28.85万港元
华健未来-B(06132.HK)11月9日斥资28.85万港元回购9000股
智通财经 · 11-09
华健未来-B(06132.HK)11月9日斥资28.85万港元回购9000股
华健未来-B于11月6日斥资19.11万港元回购6000股
新浪港股 · 11-08
华健未来-B于11月6日斥资19.11万港元回购6000股
华健未来-B:11月6日回购6,000股,涉资约19.11万港元
公告速递 · 11-06
华健未来-B:11月6日回购6,000股,涉资约19.11万港元
华健未来-B(06132)11月6日斥资19.11万港元回购6000股
智通财经 · 11-06
华健未来-B(06132)11月6日斥资19.11万港元回购6000股
盘中股价最高涨幅近20%。回购公告成华健未来-B(06132)股价反弹关键?
智通财经 · 11-03
盘中股价最高涨幅近20%。回购公告成华健未来-B(06132)股价反弹关键?
华健未来-B:11月2日回购1万股,涉资约29.19万港元
公告速递 · 11-02
华健未来-B:11月2日回购1万股,涉资约29.19万港元
华健未来-B更新10月股份变动月报表,股本维持稳定
公告速递 · 11-02
华健未来-B更新10月股份变动月报表,股本维持稳定
华健未来-B:拟不超过1亿港元回购H股
南方财经网 · 11-02
华健未来-B:拟不超过1亿港元回购H股
华健未来-B(06132.HK)拟斥资不超过1亿港元进行股份购回
智通财经 · 11-02
华健未来-B(06132.HK)拟斥资不超过1亿港元进行股份购回
华健未来-B(06132)宣布拟动用不超过1亿港元回购H股
公告速递 · 11-02
华健未来-B(06132)宣布拟动用不超过1亿港元回购H股
华健未来-B2026年9月股份变动月报:股本保持稳定
公告速递 · 09-30
华健未来-B2026年9月股份变动月报:股本保持稳定
华健未来-B(06132)公布最新董事会及三大专门委员会成员名单
公告速递 · 09-14
华健未来-B(06132)公布最新董事会及三大专门委员会成员名单
华健未来-B(06132)公布2026年9月14日临时股东大会表决结果 全部议案获高票通过
公告速递 · 09-14
华健未来-B(06132)公布2026年9月14日临时股东大会表决结果 全部议案获高票通过
华健未来-B8月股份变动月报:股本维持不变
公告速递 · 09-03
华健未来-B8月股份变动月报:股本维持不变
华健未来-B(06132)发布中期业绩,股东应占亏损7347.5万元 同比增加38.77%
智通财经 · 08-29
华健未来-B(06132)发布中期业绩,股东应占亏损7347.5万元 同比增加38.77%
华健未来-B 2026年中期业绩:收入194.30万元,经调整净亏损4,730.20万元
公告速递 · 08-28
华健未来-B 2026年中期业绩:收入194.30万元,经调整净亏损4,730.20万元
加载更多
公司概况
公司名称:
华健未来-B
所属市场:
SEHK
上市日期:
--
主营业务:
华健未来(成都)科技股份有限公司是一家主要从事小分子新药研发的中国公司。该公司主要产品包括选择性酪氨酸激酶2(TYK2)抑制剂HJ787、可口服药物HJ178、口服Kirsten大鼠肉瘤2病毒癌基因同源物(KRAS)G12C抑制剂HJ891、以及候选药物HJ197、HJ356、HJ093及HJ199。该公司产品主要用于治疗自身免疫范畴的各种皮肤病、2型糖尿病、超重或肥胖、心血管疾病及动脉粥样硬化、非小细胞肺癌(NSCLC)、晚期肝细胞癌(HCC)等疾病。该公司主要在中国国内市场开展业务。
发行价格:
--
{"stockData":{"symbol":"06132","market":"HK","secType":"STK","nameCN":"华健未来-B","latestPrice":33.44,"timestamp":1794470884832,"preClose":33.14,"halted":0,"volume":81800,"delay":0,"changeRate":0.009052504526252177,"floatShares":73561600,"shares":73561600,"eps":-2.28,"marketStatus":"已收盘","change":0.3,"latestTime":"11-12 16:08:04","open":33.14,"high":34.98,"low":32.12,"amount":2691940,"amplitude":0.086301,"askPrice":34.08,"askSize":500,"bidPrice":33.44,"bidSize":200,"shortable":0,"etf":0,"ttmEps":-2.434,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1794533400000},"marketStatusCode":5,"adr":0,"listingDate":1782144000000,"exchange":"SEHK","adjPreClose":33.14,"openAndCloseTimeList":[[1794447000000,1794456000000],[1794459600000,1794470400000]],"volumeRatio":0.814417,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/06132","defaultTab":"news","newsList":[{"id":"1135516699","title":"华健未来-B回购4,000股,耗资约12.95万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1135516699","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1135516699?lang=zh_cn&edition=full","pubTime":"2026-11-11 17:36","pubTimestamp":1794389762,"startTime":"0","endTime":"0","summary":"华健未来(成都)科技股份有限公司于2026年11月11日公告,回购4,000股H股,占2026年11月10日公司已发行股本的约0.0054%。本次回购价格区间为每股31.48港元至33.14港元,平均回购价约32.385港元,合计支付约12.95万港元。该公司于2026年9月14日通过的购回授权允许回购最多7,359,960股股份,截至目前合计在联交所以及其他证券交易所购回的股份数目为38,000股,占授权通过当日已发行股本的约0.0516%。公司确认其已遵守香港联合交易所有限公司证券上市规则及其他适用法律法规。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"华健未来-B回购4,000股,耗资约12.95万港元","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06132"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1176382004","title":"华健未来-B11月10日回购9000股,耗资约28.69万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1176382004","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1176382004?lang=zh_cn&edition=full","pubTime":"2026-11-10 17:51","pubTimestamp":1794304309,"startTime":"0","endTime":"0","summary":"华健未来(成都)科技股份有限公司于2026年11月10日发布公告,披露一笔股份回购交易。公告显示,公司于香港联交所场内回购9000股普通股H股,约占公司当日前已发行股本的0.0122%。公司本次回购的每股价格介于港币31.58元至32.36元,总计支付约28.69万港元。公司表示,此次回购是依据2026年9月14日获得的回购授权进行,当前剩余可回购股份数量为7,359,960股。公司同时确认,本次回购符合香港联交所证券上市规则及相关法律法规的要求。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"华健未来-B11月10日回购9000股,耗资约28.69万港元","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06132"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2682398482","title":"华健未来-B(06132.HK)11月10日斥资约28.69万港元回购9000股","url":"https://stock-news.laohu8.com/highlight/detail?id=2682398482","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2682398482?lang=zh_cn&edition=full","pubTime":"2026-11-10 17:47","pubTimestamp":1794304054,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1161","06132"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1159704176","title":"华健未来-B:11月9日回购9,000股,耗资约28.85万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1159704176","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1159704176?lang=zh_cn&edition=full","pubTime":"2026-11-09 17:31","pubTimestamp":1794216692,"startTime":"0","endTime":"0","summary":"华健未来(成都)科技股份有限公司于2026年11月9日发布公告,披露当日通过香港联交所场内回购9,000股普通股H股,占同期已发行股本约0.0122%。此次回购的每股价格介乎港币31.70元至32.72元,涉资总额港币288,458元,折合约28.85万港元。公司方面确认,此次回购遵守香港联合交易所有限公司证券上市规则及相关法律法规,并已履行相应程序。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"华健未来-B:11月9日回购9,000股,耗资约28.85万港元","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06132"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2682052938","title":"华健未来-B(06132.HK)11月9日斥资28.85万港元回购9000股","url":"https://stock-news.laohu8.com/highlight/detail?id=2682052938","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2682052938?lang=zh_cn&edition=full","pubTime":"2026-11-09 17:29","pubTimestamp":1794216589,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1161","06132"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2681424898","title":"华健未来-B于11月6日斥资19.11万港元回购6000股","url":"https://stock-news.laohu8.com/highlight/detail?id=2681424898","media":"新浪港股","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2681424898?lang=zh_cn&edition=full","pubTime":"2026-11-08 16:12","pubTimestamp":1794125520,"startTime":"0","endTime":"0","summary":"热点栏目自选股\n数据中心\n行情中心\n资金流向\n模拟交易客户端华健未来-B(06132)发布公告,于2026年11月6日,该公司斥资19.11万港元回购6000股股份,每股回购价31.54-31.98港元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2026-11-08/doc-inixzhuu7100849.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1161","06132"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1198104638","title":"华健未来-B:11月6日回购6,000股,涉资约19.11万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1198104638","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1198104638?lang=zh_cn&edition=full","pubTime":"2026-11-06 17:51","pubTimestamp":1793958686,"startTime":"0","endTime":"0","summary":"华健未来(成都)科技股份有限公司于2026年11月6日发布公告,披露公司在香港联交所场内回购6,000股,占当日回购前已发行股本约0.0082%。本次回购价格介于每股31.54港元至31.98港元之间,总金额约19.11万港元。回购后,公司已发行股本变动为73,583,605股,库藏股数量增至16,000股。公司确认已遵守香港联合交易所有限公司证券上市规则的相关规定。本公告由联席公司秘书张菁洁签署。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"华健未来-B:11月6日回购6,000股,涉资约19.11万港元","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06132"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2681548358","title":"华健未来-B(06132)11月6日斥资19.11万港元回购6000股","url":"https://stock-news.laohu8.com/highlight/detail?id=2681548358","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2681548358?lang=zh_cn&edition=full","pubTime":"2026-11-06 17:49","pubTimestamp":1793958576,"startTime":"0","endTime":"0","summary":"智通财经APP讯,华健未来-B(06132)发布公告,于2026年11月6日,该公司斥资19.11万港元回购6000股股份,每股回购价31.54-31.98港元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1519760.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","06132"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680379711","title":"盘中股价最高涨幅近20%。回购公告成华健未来-B(06132)股价反弹关键?","url":"https://stock-news.laohu8.com/highlight/detail?id=2680379711","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2680379711?lang=zh_cn&edition=full","pubTime":"2026-11-03 13:31","pubTimestamp":1793683901,"startTime":"0","endTime":"0","summary":"11月2日盘前,华健未来-B发布公告宣布,公司董事会已决议行使购回股份授权,拟于购回股份授权有效期内不时于公开市场购回H股,总金额不超过1亿港元。在华健未来当日开盘至触高期间,公司股价的盘中卖压几乎为零,也就是说买方以较小代价完成价格推升。实际上,华健未来的股价弹性根源在于其极低的流通筹码集中度。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1517632.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","06132"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1152804459","title":"华健未来-B:11月2日回购1万股,涉资约29.19万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1152804459","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1152804459?lang=zh_cn&edition=full","pubTime":"2026-11-02 18:41","pubTimestamp":1793616098,"startTime":"0","endTime":"0","summary":"华健未来-B(股票代码:06132)于2026年11月2日发布公告,披露公司当日在香港联交所场内回购股份。根据公告,公司合计回购1万股普通股,占本次回购前公司已发行股本约0.0136%。每股回购价格介于每股港币28.58元至29.36元,总耗资约29.19万港元。\n本次回购完成后,公司已发行股本变为73,589,605股,另有1万股作为库藏股,合计73,599,605股。公司已于2026年9月14日通过购回授权,可回购的股份总数为7,359,960股。\n公司确认已遵守香港联交所主板上市规则及相关法律法规的规定。本公告由联席公司秘书张菁洁签署。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"华健未来-B:11月2日回购1万股,涉资约29.19万港元","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06132"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1169658834","title":"华健未来-B更新10月股份变动月报表,股本维持稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=1169658834","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1169658834?lang=zh_cn&edition=full","pubTime":"2026-11-02 16:36","pubTimestamp":1793608585,"startTime":"0","endTime":"0","summary":"华健未来(成都)科技股份有限公司于2026年11月2日发布的2026年10月股份变动月报表显示,截至10月31日,公司普通股注册股本总额为人民币73,599,605元,已发行的普通股股数为73,599,605股,面值为每股人民币1元,较上月底无增减变化。公司确认截至本月末已符合香港联合交易所有限公司相关上市规则规定的最低公眾持股量要求。公司表示,将继续严格遵守香港联交所《上市规则》和有关法律法规的相关要求,确保股本结构信息透明、合规。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06132"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680788219","title":"华健未来-B:拟不超过1亿港元回购H股","url":"https://stock-news.laohu8.com/highlight/detail?id=2680788219","media":"南方财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2680788219?lang=zh_cn&edition=full","pubTime":"2026-11-02 06:48","pubTimestamp":1793573280,"startTime":"0","endTime":"0","summary":"南财智讯11月2日电,华健未来-B(06132.HK)发布自愿公告,公司董事会获授权回购H股,拟于公开市场回购H股,总金额不超过1亿港元。公司拟以内部资源为股份回购提供资金。董事会认为,H股近期交易价格未能充分反映公司内在价值及长远发展前景,进行股份回购有助于提升股东价值。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202611023917839215.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202611023917839215.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["06132","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680303788","title":"华健未来-B(06132.HK)拟斥资不超过1亿港元进行股份购回","url":"https://stock-news.laohu8.com/highlight/detail?id=2680303788","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2680303788?lang=zh_cn&edition=full","pubTime":"2026-11-02 06:16","pubTimestamp":1793571361,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1161","06132"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1185017604","title":"华健未来-B(06132)宣布拟动用不超过1亿港元回购H股","url":"https://stock-news.laohu8.com/highlight/detail?id=1185017604","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1185017604?lang=zh_cn&edition=full","pubTime":"2026-11-02 06:11","pubTimestamp":1793571080,"startTime":"0","endTime":"0","summary":"华健未来(成都)科技股份有限公司11月2日发布自愿公告称,董事会已决定行使股东于2026年9月14日临时股东大会授权的H股一般回购权,计划在授权有效期内通过公开市场回购公司H股,总金额不超过1亿港元。公司指出,近期H股交易价格未能充分反映其内在价值及长远发展前景,回购将有助于提升股东价值。公司提醒投资者,能否实施回购及其规模、时间和价格均存在不确定性,投资者在买卖公司H股时应保持审慎。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06132"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1145579350","title":"华健未来-B2026年9月股份变动月报:股本保持稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=1145579350","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1145579350?lang=zh_cn&edition=full","pubTime":"2026-09-30 19:22","pubTimestamp":1790767366,"startTime":"0","endTime":"0","summary":"华健未来(成都)生物科技股份有限公司于2026年9月30日披露了2026年9月股份变动月报表,报告期为截至2026年9月30日。公告显示,公司法定/注册股本数为人民币73,599,605元,已发行普通股H股股数为73,599,605股,面值为每股人民币1元。与上个月相比,本期股本保持不变。此外,公司确认,截至9月30日已符合香港联交所关于最低公众持股量的要求。公司同时重申已遵守香港联交所《上市规则》及相关法律法规的要求。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06132"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1146965295","title":"华健未来-B(06132)公布最新董事会及三大专门委员会成员名单","url":"https://stock-news.laohu8.com/highlight/detail?id=1146965295","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1146965295?lang=zh_cn&edition=full","pubTime":"2026-09-14 18:16","pubTimestamp":1789381000,"startTime":"0","endTime":"0","summary":"2026年9月14日,华健未来(成都)科技股份有限公司在港交所披露董事名册及其在各专门委员会中的职能分工。公司现设审核委员会、薪酬与考核委员会及提名委员会。上述董事会及各专门委员会的组成信息以2026年9月14日发布的公告为准。公司称,相关董事及委员会成员的任命已按香港联合交易所有限公司及公司章程的有关规定履行必要程序。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06132"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1152839861","title":"华健未来-B(06132)公布2026年9月14日临时股东大会表决结果 全部议案获高票通过","url":"https://stock-news.laohu8.com/highlight/detail?id=1152839861","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1152839861?lang=zh_cn&edition=full","pubTime":"2026-09-14 18:13","pubTimestamp":1789380790,"startTime":"0","endTime":"0","summary":"2026年9月14日,华健未来-B在成都召开临时股东大会。会议就五项特别决议案及两项普通决议案进行投票表决,所有议案均获股东正式通过。以下为核心数据:。会议当日公司已发行H股总数为73,599,605股。出席会议并行使表决权的股东及其受委代表合计持有52,488,060股,占已发行股份总数约71.32%。变更公司名称:赞成票52,488,060股,反对及弃权票均为0股。两项普通决议案均获过半数投票赞成,顺利通过。香港中央证券登记有限公司作为本次临时股东会的点票监票人。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06132"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1141345318","title":"华健未来-B8月股份变动月报:股本维持不变","url":"https://stock-news.laohu8.com/highlight/detail?id=1141345318","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1141345318?lang=zh_cn&edition=full","pubTime":"2026-09-03 17:01","pubTimestamp":1788426101,"startTime":"0","endTime":"0","summary":"华健未来(成都)科技股份有限公司于2026年9月3日发布截至2026年8月31日的股份变动月报表。根据公告显示,截至8月底,公司无新增股份发行、回购、注销或库藏股变动,股本规模保持稳定。截至报告期末,公司确认符合香港联交所规定的最低公众持股量要求。公告同时显示,本月并无股份期权、权证或可换股票据等方面的发行或变动。公司表示将继续密切关注股本情况,确保合规稳健运营。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06132"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663609096","title":"华健未来-B(06132)发布中期业绩,股东应占亏损7347.5万元 同比增加38.77%","url":"https://stock-news.laohu8.com/highlight/detail?id=2663609096","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663609096?lang=zh_cn&edition=full","pubTime":"2026-08-29 01:09","pubTimestamp":1787936977,"startTime":"0","endTime":"0","summary":"智通财经APP讯,华健未来-B(06132)发布截至2026年6月30日止6个月的中期业绩,该集团取得收入人民币194.3万元(单位下同),同比增加118.1%;本公司拥有人应占亏损7347.5万元,同比增加38.77%;每股亏损1.21元。公告称,收入增加主要由于2025年7月收到筠泽创曜的2000万元里程碑付款以及集团于报告期内持续履行相关研发服务履约义务,按成本投入法计量的履约进度提高。该款项乃根据实际产生成本占全面履行集团履约义务所需估计总成本的百分比随时间确认为收入,而未确认部分则呈列为合约负债。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1488849.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","06132"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1100384524","title":"华健未来-B 2026年中期业绩:收入194.30万元,经调整净亏损4,730.20万元","url":"https://stock-news.laohu8.com/highlight/detail?id=1100384524","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1100384524?lang=zh_cn&edition=full","pubTime":"2026-08-28 23:04","pubTimestamp":1787929440,"startTime":"0","endTime":"0","summary":"2026年上半年,华健未来-B(股票代码:06132)实现收入194.30万元,同比增长118.1%。同期,公司经调整净亏损为4,730.20万元,同比收窄10.7%。\n报告期内,华健未来-B的研发开支为4,625.50万元,较上一年同期增长13.1%。同时,行政开支约2,096.40万元,相比上一期约911.90万元增长约130%。经营活动所用现金净额约5,377.60万元,与上年同期基本持平。\n截至2026年6月30日,公司持有的现金及现金等价物为11.07亿元,同比增长29,654.9%。\n(文中金额如无特别说明,均已根据公告“人民币千元”口径换算后四舍五入,单位为“万元”或“亿元”)","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"华健未来-B 2026年中期业绩:收入194.30万元,经调整净亏损4,730.20万元","news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06132"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.hj3h.com","stockEarnings":[{"period":"1week","weight":0.026},{"period":"1month","weight":-0.0945},{"period":"3month","weight":-0.1917},{"period":"6month","weight":-0.5949},{"period":"ytd","weight":-0.5949}],"compareEarnings":[{"period":"1week","weight":0.0166},{"period":"1month","weight":0.0018},{"period":"3month","weight":-0.0425},{"period":"6month","weight":-0.0634},{"period":"1year","weight":-0.0892},{"period":"ytd","weight":-0.0513}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"华健未来(成都)科技股份有限公司是一家主要从事小分子新药研发的中国公司。该公司主要产品包括选择性酪氨酸激酶2(TYK2)抑制剂HJ787、可口服药物HJ178、口服Kirsten大鼠肉瘤2病毒癌基因同源物(KRAS)G12C抑制剂HJ891、以及候选药物HJ197、HJ356、HJ093及HJ199。该公司产品主要用于治疗自身免疫范畴的各种皮肤病、2型糖尿病、超重或肥胖、心血管疾病及动脉粥样硬化、非小细胞肺癌(NSCLC)、晚期肝细胞癌(HCC)等疾病。该公司主要在中国国内市场开展业务。","exchange":"SEHK","name":"华健未来-B","nameEN":"HJ SCIENCE-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.53.0","shortVersion":"4.53.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"华健未来-B(06132)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供华健未来-B(06132)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"华健未来-B,06132,华健未来-B股票,华健未来-B股票老虎,华健未来-B股票老虎国际,华健未来-B行情,华健未来-B股票行情,华健未来-B股价,华健未来-B股市,华健未来-B股票价格,华健未来-B股票交易,华健未来-B股票购买,华健未来-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"华健未来-B(06132)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供华健未来-B(06132)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}